Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Hematology. American Society of Hematology. Education Program
|
December 9, 2022
Optimal approach to T-cell ALL
Kristen M O'Dwyer
Seminars in Hematology
|
December 1, 2020
The challenge to further improvements in survival of patients with T-ALL: Current treatments and new insights from disease pathogenesis
Kristen M O'Dwyer
Hematology. American Society of Hematology. Education Program
|
December 5, 2025
Immune targeting in Ph-negative and Ph-positive B-ALL: improving outcomes and minimizing chemotherapy in adult B-ALL
Kristen M O'Dwyer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 25, 2015
When to Treat Adults Like Children: Optimizing Therapy for Lymphoblastic Lymphoma in Young Adults
Kristen M O'Dwyer, Anjali S Advani
Best Practice & Research. Clinical Haematology
|
October 21, 2017
Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in older adults: Current treatment and novel therapies
Kristen M O'Dwyer, Jane L Liesveld
Journal of Geriatric Oncology
|
April 10, 2018
Can we incorporate geriatric assessment in the management of acute lymphoblastic leukemia in older adults?
Kah Poh Loh, Jane L Liesveld, Kristen M O'Dwyer
ACS Chemical Biology
|
November 12, 2013
Discovery of potent parthenolide-based antileukemic agents enabled by late-stage P450-mediated C-H functionalization
Joshua N Kolev, Kristen M O'Dwyer, Craig T Jordan, et al.
Bioorganic & Medicinal Chemistry
|
July 12, 2016
Chemoenzymatic synthesis and antileukemic activity of novel C9- and C14-functionalized parthenolide analogs
Vikas Tyagi, Hanan Alwaseem, Kristen M O'Dwyer, et al.
Leukemia Research
|
November 28, 2021
A phase II study of sequential decitabine and rapamycin in acute myelogenous leukemia
Jane L Liesveld, Andrea Baran, Mitra Azadniv, et al.
Blood Neoplasia
|
May 7, 2026
Prioritized health outcomes for adolescents and young adults with acute lymphoblastic leukemia
Ian J Saldanha, Yuliia Sereda, Ghid Kanaan, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Hematology. American Society of Hematology. Education Program
|
December 9, 2022
Optimal approach to T-cell ALL
Kristen M O'Dwyer
Seminars in Hematology
|
December 1, 2020
The challenge to further improvements in survival of patients with T-ALL: Current treatments and new insights from disease pathogenesis
Kristen M O'Dwyer
Hematology. American Society of Hematology. Education Program
|
December 5, 2025
Immune targeting in Ph-negative and Ph-positive B-ALL: improving outcomes and minimizing chemotherapy in adult B-ALL
Kristen M O'Dwyer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 25, 2015
When to Treat Adults Like Children: Optimizing Therapy for Lymphoblastic Lymphoma in Young Adults
Kristen M O'Dwyer, Anjali S Advani
Best Practice & Research. Clinical Haematology
|
October 21, 2017
Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in older adults: Current treatment and novel therapies
Kristen M O'Dwyer, Jane L Liesveld
Journal of Geriatric Oncology
|
April 10, 2018
Can we incorporate geriatric assessment in the management of acute lymphoblastic leukemia in older adults?
Kah Poh Loh, Jane L Liesveld, Kristen M O'Dwyer
ACS Chemical Biology
|
November 12, 2013
Discovery of potent parthenolide-based antileukemic agents enabled by late-stage P450-mediated C-H functionalization
Joshua N Kolev, Kristen M O'Dwyer, Craig T Jordan, et al.
Bioorganic & Medicinal Chemistry
|
July 12, 2016
Chemoenzymatic synthesis and antileukemic activity of novel C9- and C14-functionalized parthenolide analogs
Vikas Tyagi, Hanan Alwaseem, Kristen M O'Dwyer, et al.
Leukemia Research
|
November 28, 2021
A phase II study of sequential decitabine and rapamycin in acute myelogenous leukemia
Jane L Liesveld, Andrea Baran, Mitra Azadniv, et al.
Blood Neoplasia
|
May 7, 2026
Prioritized health outcomes for adolescents and young adults with acute lymphoblastic leukemia
Ian J Saldanha, Yuliia Sereda, Ghid Kanaan, et al.
Page
of 3